Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's all she wrote for the .26's, next stop .22 once again.... Then the plunge to the teens when there's no data in October.
60k ask at .263... That will set the tempo for the dramatic last hour of trading.
Readying for the quarter per share dance..... What a sign of things to come for late November’s report. Leo will sit on results knowing the end is near. He and Jane a few more paychecks remain.
Patients are not provided the manufacturer....Does anyone believe that info is secret? If more than half the patients recovered because of IPIX it would have leaked... This stock has gone down since trial completion.
Google search for COVID trials in Russia would have easily given away any secrets... Those administering and trial participants could easily find out.... Hell, someone here found the Russian trial locations before they were posted on the FDA site.... LOL
Correct, just like CTIX stock lagged ahead of Prurisol results this time is no different... If B was a magical solution it would have leaked out by now not only at home or by the Russians... Someone over there surely would have investigated and connected the Dots....
Leo said data a week after a lock.... Where's the lock PR? He has 2 more days to make October...
Data in November is now anticipated.... Still no lock PR is the clue...
In reality, the stock trading at 26 pennies is basically finished to most investors. If not for Covid there would be no IPIX today... As far as being critical of ones investment was not directed at the science but the man who's been in charge. Leo survived this long because you and others gave him a free pass. The only accountability has been the stock price... The real world Leo would have been gone years ago shortly after the stock up-listing disaster...
I'm here like you and many others who got sucked into this and hope to see a buck.... Covid gave IPIX a 2 year extension now time is up... K/P brought me here, those 2 are obsolete... A complete sale above a buck and many will be even or close... That's how terrible this stock/CEO has performed...
Let me get this straight, Prurisol was compared heavily to Otezla but somehow they ran into funding issues for 189 subjects... You really buy that garbage for why there was a 5 month gap between the lock PR and data release? They knew long before December it failed.... This trial has more subjects with less funding available... Finally, we'll know the status of IPIX in a few weeks... Sold or fold...
Yes, the rally to .295 had no volume as well... This will drift with no direction until the lock PR....
Stock is heading back down the toilet no surprise... The 8K rally lasted 2 days once reality set in... The lock PR should have occurred by now or no longer than this Friday.... Hedge your bets...
That's BS, he issued a data release in a filing and didn't have the guts to report in a PR... He knew all along it failed... The lock PR was issued in July of that year, we found out about data in December. They didn't have the funding is pure nonsense... They had Aspire's money at the time and were in better shape than now...
Leo also issued a statement where results would occur one week after a lock... Does anyone believe data only takes a week after a lock and if so will we see a PR? Leo causes more harm than good by statements designed to sell shares...
In reality, phase 2 results could be great but what happens after is the game changer... Will they get EUA from the FDA or another country? Or need a phase 3.... The difference on this trading 2 bucks or 30 cents....
If there's no lock PR or data by Friday this will trade back down to the low .20's... All momentum anticipating results will then focus on Leo being late or a data miss.....
Did Leo sit on P data or not? That's the concern here if data misses... Why Leo used ANTICIPATED and data a week after a lock... Why bring up a lock at all if he planned on not issuing a PR?
It's not a company.... 2 employees, 2 BODS is laughable...
You mean if they have good data to report... All 2 million shares shorted are worried to death....
Really, you give Leo too much credit for being a lousy CEO... The results are later than many expected with each passing day diminishing returns. Mid to late 2022 for approval? LOL
So why did Leo mention data a week after a lock? He should have left that out if his intentions were to surprise... Next week the concern will be this dragging into November or worse sitting on results like Prurisol... I'm expecting a lock PR then tack on one or two weeks for results... Mid to late November my anticipated guess...
Your anticipating he's bypassing a lock PR.... Results could drag on until Turkey Day....
More detailed explanation on buyouts. https://www.upcounsel.com/if-company-is-bought-what-happens-to-stock
Buyout options: stock deal, all cash or both..... Stock deal you would get all GLD shares at the ratio of the agreement. 5 bucks you’d get 1 share of GLD for every 30 shares of IPIX if GLD trades at 150 for the accepted buyout. Cash deal you’d get all cash and have no equity, both some cash and shares. Those who do not want GLD stock will have time to sell IPIX which will be tied to GLDs price movement. Example: If the buyout is 5 bucks and GLD drops 10 percent before the deal is official your IPIX shares will be around 4.50. 5.50 if GLD goes up 10 percent. 5 bucks per/share is a stretch for anyone to pay Leo over 2 billion. 1 to 2 bucks more in reality.
The only way I see a partnership would be EUA acceptance... Leo won't find anyone to do a license deal where partner X assumes all costs going forward also paying Leo upfront and royalties... The biggest unknown would be P3 completion and costs... Would there be any profit? A buyout provides full control of the entire B platform in case B for C does not pan out with K a wildcard.... Expecting 2.50 at most which makes many here wealthy. This chatter only happens if data pans out....
A buyout will adjust the PPS upward to the negotiated deal but will take some time to close so IPIX will still trade. A short will have time to cover or hold until conversion.
Why would partner A pay IPIX let’s say 10 million upfront, all phase 3 costs (30 million) before an approval would be known? If approved another 20 million or more for manufacturing and logistics..... In a year who knows if the virus will still be around? Why a Buyout for B total or IPIX as a whole makes more sense. They would still have B-UP and OM to justify millions. Leo wants to unload IPIX and begin retirement he has no aspirations to play biotech build or we’d see signs long ago with hirings.
Lemon, you mean an anticipated release a week after a lock. This could drag on until December if Leo sits on results or takes longer.
Why do many here assume a partnership makes sense for all parties involved? Doubt very much someone will give Leo X many millions upfront, royalties if approved and pay most or all the costs which includes phase 3, manufacturing and then logistics..... Cmon folks there’s going to be either a complete sale of B or IPIX as a whole depending if K has any interest. Leo is not structured to run a business much past data release. 2 employees the past year is the biggest clue. If there’s a data miss all bets are off.....
Why wouldn't they increase authorized shares knowing it would be needed for the compensation plans? Although, if there's a data miss it won't matter unless Leo believes he can dilute shares under 10 pennies for another year?
An Alphasigma trial would be a must Q1 2022...
Expecting a doubling of authorized shares Mon/Tue with results in a few weeks. This is all meaningless (compensation/increased shares) if they miss data. Stock will trade back to 6 pennies and basically end IPIX's existance...
Why wouldn't he take one or two billion? One would value the deal at 2.25 the other 4.50 per/share... Revenues from B Cv19 would still be an unknown until they would be approved after a P3 or EUA... Any buyer knows the true worth and will not pay much more than a buck or two. IPIX has no other revenue sources....
Leo also issued this after 9/30 to escape full details until next year Q4 filing. Wonder if he’ll increase authorized shares ahead of data while there is still interest in the stock? After a miss could spell even more disaster.
WTH Bid .2602, Ask .295? This market needs some regulation.... LOL
In theory wouldn't Alphasigma be the most likely buyer of IPIX? They would then own all rights to B and look upon K as a working project.... They've already done business and have a pending trial together...
May hit your .30 today... Results imminent... Leo has had plenty of time to negotiate a sale/partner waiting for results to confirm.... Never bought the theory he'd keep ongoing with he/Jane... Who knows maybe Alphasigma is the buyer....
Russia breaks record for cases/deaths.... Don't rule out this option for EUA as well... Heck, they had most for the trial there...
https://news.yahoo.com/russia-marks-pandemics-record-daily-104004592.html
No chance Leo will see a 2 billion offer... He would need EUA and still don't see them getting anywhere near 2 bucks... 500 to 750 million at most....
LR, maybe Leo will hire you on as their third employee? He needs some help dotting his I's and crossing his T's... In reality, everything rides on data while side chatter is speculation. We do know employee count is not adequate enough to run a Rita's Water Ice dismissing speculation that IPIX is a long-term business ripe for expansion...